Mark Cuban Cost Plus Drug Company Teams Up with RxLink to Bring Pharmacy Cost Transparency to Patients of Leading Health Systems
DOVER, Del., May 7, 2024 /PRNewswire/ -- Today, RxLink, a firm founded with the same commitment to price transparency in prescription medicine as Mark Cuban Cost Plus Drug Company, PBC (Cost Plus Drugs) announced a new collaboration to connect patients of leading health systems with Cost Plus Drugs' offering of safe medicines at the lowest possible price.
- Patients Automatically Receive Information on Pricing of Prescribed Medications, Including Cost Plus Drugs' Transparent Pricing
DOVER, Del., May 7, 2024 /PRNewswire/ -- Today, RxLink, a firm founded with the same commitment to price transparency in prescription medicine as Mark Cuban Cost Plus Drug Company, PBC (Cost Plus Drugs) announced a new collaboration to connect patients of leading health systems with Cost Plus Drugs' offering of safe medicines at the lowest possible price. - The MedMap™ now includes Cost Plus Drugs and has already identified and surfaced over $162,000 in patient savings after only 3 months of including Cost Plus Drugs pricing.
- "We are excited to work with RxLink to bring lower prescription drug prices to consumers," said Alex Oshmyansky, CEO of Mark Cuban Cost Plus Drug Company.
- "Cost Plus Drugs and RxLink share a common goal of providing consumers the lowest possible price for their prescription medication.